SI Group Announces New Executive Leadership

Food and Healthcare Press Releases Tuesday November 6, 2018 12:40
SCHENECTADY, N.Y.--6 Nov--PRNewswire/InfoQuest
  • Announcement Follows Completion of Sale to SK Capital Partners

SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, announced today the company's new executive leadership team. These changes follow the October 15, 2018 completion of the acquisition of SI Group by SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors. The transaction included the combination of SI Group with Addivant, an SK Capital portfolio company since 2013 and leading global producer of specialty additives. The newly combined company is marketed under the SI Group brand, and is led by the following executive leadership team:

  • Frank Bozich, SI Group CEO
  • John Steitz, CEO, Additives
  • Chris Cornille, Senior Vice President, Supply Chain Services
  • Brooke Manrique, Senior Vice President, Human Resources & Communications
  • Tom Masterson, Senior Vice President, General Counsel & Regulatory Affairs
  • Wei Ru, Senior Vice President, Engineering & Process Technology
  • Paul Tilley, Senior Vice President, Chemical Intermediates & Industrial Resins
  • Patrick Weinberg, Senior Vice President & Chief Financial Officer
  • Rich White, Senior Vice President, Manufacturing & EHSQ

Additionally, the new company has been structured around several strategic business units that will focus exclusively on product offerings and innovation, as well as superior customer relationship management. These leaders include:

  • Katie Ellet, Vice President, Oilfield Solutions
  • Philip Ingham, Vice President, Industrial Resins & Specialties
  • Robert Kaiser, Vice President, Rubber & Adhesives
  • Chris Roberts, Vice President, Fuels & Lubricants

SI Group is led by Frank Bozich and John Steitz, proven chemical industry leaders with over 75 years of collective expertise. "These organizational changes leverage the key competencies and capabilities of our leadership teams. The structure enables a strong external focus, cultivating more collaborative relationships with our customers," said Frank Bozich, CEO. John Steitz, CEO Additives, added, "We will be more adept at delivering superior customer value and more thoughtful, systematic and anticipatory to changes in global market forces that impact the industry."

Biographies may be found at http://www.siigroup.com/leadership.asp.
ABOUT SI GROUP

SI Group is a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, with strong market positions in the plastics, oilfield, rubber, fuels & lubricants, active pharmaceutical ingredients and industrial resins industries. SI Group solutions are critical to the quality and performance of countless industrial and consumer goods. Headquartered in Schenectady, New York, SI Group operates more than 30 manufacturing facilities on five continents with approximately $2 billion in annual sales, and more than 3,000 employees worldwide. SI Group is a portfolio company of SK Capital Partners. In 2018, SI Group received its third silver award for corporate social responsibility by EcoVadis, and is ranked among the top seven percent of more than 45,000 worldwide companies. SI Group is The Substance Inside. For more information, please visit www.siigroup.com.

Media Contact:
Tara Morgan
SI Group, Inc.
+ 1 518-347-4194
tara.morgan@siigroup.com
Photo- https://mma.prnewswire.com/media/779723/SI_Group_Global_Headquarters.jpg
Logo- https://mma.prnewswire.com/media/95496/si_group__inc__logo.jpg

Latest Press Release

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Infringement of Technology Used for Echosens# FibroScan(R), Imposes Damages Orders Halt to Manufacturing and Sales

Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, today announces that the Beijing Intellectual Property Court has confirmed judgment against Wuxi Hisky Medical,...

5 Ways to Set Healthy Grocery Shopping Habits in 2019

By Susan Bowerman, M.S., RD, CSSD, CSOWM, FAN, Senior Director, Worldwide Nutrition Education and Training Make your daily staples as healthy as you can. Small changes in the foods you eat every day can add up to big rewards. The holidays are over, and...

Related Topics